Epigenetics in autoimmune diseases with focus on type 1 diabetes

Autoimmune diseases arise when the body mounts an immune response against ‘self’ cells and tissues causing inflammation and damage. It is commonly accepted that these diseases develop because of the interplay of genetic and environmental factors. Evidence for genetic factors includes the higher concordance of disease in monozygotic twins than in dizygotic twins. However, monozygotic twins may remain discordant for disease indicating a role for environmental factors. Environmental factors may alter gene expression via epigenetic mechanisms. This is particularly pertinent in type 1 diabetes in which DNA methylation and histone modifications have been associated with altered gene expression. The low disease concordance rate in adult‐onset type 1 diabetes (<20%) suggests that environmental and epigenetic changes may play a predominant role. Defining the role of epigenetic changes could identify specific gene pathways and dysregulated expression of gene products that contribute to the pathogenesis of type 1 diabetes. This article reviews how epigenetic mechanisms may contribute to the development of autoimmune diseases with a focus on type 1 diabetes. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  C. Dantec,et al.  Genetics and Epigenetics of Autoimmune Diseases , 2015 .

[2]  T. Down,et al.  A functional methylome map of ulcerative colitis , 2012, Genome research.

[3]  C. McCall,et al.  MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulators , 2012, Immunology and cell biology.

[4]  M. McCarthy,et al.  Association of the CpG Methylation Pattern of the Proximal Insulin Gene Promoter with Type 1 Diabetes , 2012, PloS one.

[5]  E. Chuang,et al.  A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity , 2011, Genes and Immunity.

[6]  R. Grigg,et al.  Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. , 2012, Arthritis and rheumatism.

[7]  J. Gallo,et al.  MicroRNAs: Emerging Regulators of Immune‐Mediated Diseases , 2012, Scandinavian journal of immunology.

[8]  P. Pozzilli.  Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy , 2012, Nature Reviews Endocrinology.

[9]  Matthieu Defrance,et al.  DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients , 2012, The EMBO journal.

[10]  P. Tak,et al.  Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay , 2011, Annals of the rheumatic diseases.

[11]  W. Reik,et al.  Uncovering the role of 5-hydroxymethylcytosine in the epigenome , 2011, Nature Reviews Genetics.

[12]  P. Lizardi,et al.  Detection of β cell death in diabetes using differentially methylated circulating DNA , 2011, Proceedings of the National Academy of Sciences.

[13]  F. Dotta,et al.  Increased expression of microRNA miR‐326 in type 1 diabetic patients with ongoing islet autoimmunity , 2011, Diabetes/metabolism research and reviews.

[14]  Jun Yuan,et al.  Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells , 2011, Lupus.

[15]  P. Tak,et al.  DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts , 2011, Genes and Immunity.

[16]  F. Matschinsky,et al.  The microRNA-21−PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death , 2011, Proceedings of the National Academy of Sciences.

[17]  D. Peden.  The role of oxidative stress and innate immunity in O3 and endotoxin‐induced human allergic airway disease , 2011, Immunological reviews.

[18]  Selene L. Fernandez-Valverde,et al.  MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications , 2011, Diabetes.

[19]  Jonathan D. Wren,et al.  Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus , 2011, Epigenetics.

[20]  Q. Lu,et al.  MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. , 2011, Arthritis and rheumatism.

[21]  S. Monticelli,et al.  MiR-146a in Immunity and Disease , 2011, Molecular biology international.

[22]  Y. Dong,et al.  Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus , 2011, Lupus.

[23]  Tim D. Spector,et al.  A twin approach to unraveling epigenetics , 2011, Trends in genetics : TIG.

[24]  H. Kolb,et al.  Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 , 2011, Diabetologia.

[25]  N. Damjanov,et al.  HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis , 2011, Molecular medicine.

[26]  H. Liu,et al.  Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus , 2011, Lupus.

[27]  T. Ha.  The Role of MicroRNAs in Regulatory T Cells and in the Immune Response , 2011, Immune network.

[28]  S. G. Rønn,et al.  The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro , 2011, Molecular medicine.

[29]  S. Khosla,et al.  The DNA methyltranferase Dnmt2 participates in RNA processing during cellular stress , 2011, Epigenetics.

[30]  C. Simone,et al.  Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance , 2010, Journal of biomedicine & biotechnology.

[31]  Thomas A. Down,et al.  Identification of Type 1 Diabetes–Associated DNA Methylation Variable Positions That Precede Disease Diagnosis , 2010, PLoS genetics.

[32]  Kristin Andrews,et al.  Evidence and implications , 2011 .

[33]  Gang Wang,et al.  Serum and Urinary Cell–free MiR-146a and MiR-155 in Patients with Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.

[34]  Yuanjia Tang,et al.  MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. , 2010, Arthritis and rheumatism.

[35]  J. Ilonen,et al.  Enterovirus RNA in Blood Is Linked to the Development of Type 1 Diabetes , 2010, Diabetes.

[36]  I. Georgiou,et al.  A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. , 2010, Joint, bone, spine : revue du rhumatisme.

[37]  Stephan Beck,et al.  Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus , 2010, BMC Medical Genomics.

[38]  R. Natarajan,et al.  The role of epigenetics in the pathology of diabetic complications. , 2010, American journal of physiology. Renal physiology.

[39]  Yuanjia Tang,et al.  MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.

[40]  Arturas Petronis,et al.  Epigenetics as a unifying principle in the aetiology of complex traits and diseases , 2010, Nature.

[41]  F. Gao,et al.  Hypomethylation of IL10 and IL13 Promoters in CD4+ T Cells of Patients with Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[42]  Yuzhang Wu,et al.  Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis , 2010, Arthritis research & therapy.

[43]  K. Hemminki,et al.  The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. , 2010, Journal of autoimmunity.

[44]  J. Pers,et al.  Epigenetics and autoimmunity. , 2010, Journal of autoimmunity.

[45]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[46]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[47]  G. Macino,et al.  miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. , 2010, Human immunology.

[48]  J. Michálek,et al.  microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. , 2010, Cellular immunology.

[49]  R. Gay,et al.  DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.

[50]  P. Pozzilli,et al.  Natural history and immunopathogenesis of type 1 diabetes. , 2009, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[51]  Yoshio Kato,et al.  MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. , 2009, Arthritis and rheumatism.

[52]  S. Miyaki,et al.  Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a. , 2009, Arthritis and rheumatism.

[53]  E. Uz,et al.  Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases , 2009, Arthritis research & therapy.

[54]  W-S Xu,et al.  Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.

[55]  Masahiro Kurosaka,et al.  MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[56]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[57]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[58]  M. Cooper,et al.  Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail , 2008, Diabetes.

[59]  Andrew Min,et al.  Lymphocytes From Patients With Type 1 Diabetes Display a Distinct Profile of Chromatin Histone H3 Lysine 9 Dimethylation , 2008, Diabetes.

[60]  Huriya Beyan,et al.  Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes , 2008, Diabetes.

[61]  R. Read,et al.  Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[62]  Kaleb M. Pauley,et al.  Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients , 2008, Arthritis research & therapy.

[63]  A. Gaikwad,et al.  Change in post‐translational modifications of histone H3, heat‐shock protein‐27 and MAP kinase p38 expression by curcumin in streptozotocin‐induced type I diabetic nephropathy , 2008, British journal of pharmacology.

[64]  S. Gay,et al.  Epigenetic clues to rheumatoid arthritis. , 2008, Journal of autoimmunity.

[65]  E. Jacobson,et al.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. , 2008, Endocrine reviews.

[66]  P. Pozzilli,et al.  Low‐risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B‐cells 12 months after diagnosis , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[67]  Q. Lu,et al.  Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus1 , 2007, The Journal of Immunology.

[68]  E. Bosi,et al.  High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes , 2007, Diabetes Care.

[69]  G. Dahlquist,et al.  Worldwide childhood type 1 diabetes incidence – what can we learn from epidemiology? , 2007, Pediatric diabetes.

[70]  Xiaodong Cheng,et al.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation , 2007, Nature.

[71]  Y. Tomer,et al.  Thyroid Epigenetics , 2007, Annals of the New York Academy of Sciences.

[72]  H. Jalahej,et al.  Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus. , 2007, Journal of autoimmunity.

[73]  H. Moch,et al.  Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. , 2007, Arthritis and rheumatism.

[74]  P. Pozzilli,et al.  A new expression of diabetes: double diabetes , 2007, Trends in Endocrinology & Metabolism.

[75]  F. Miller,et al.  Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease , 2007, Nature Clinical Practice Rheumatology.

[76]  Robert A. Martienssen,et al.  Noncoding RNAs and Gene Silencing , 2007, Cell.

[77]  E. Lander,et al.  The Mammalian Epigenome , 2007, Cell.

[78]  L. Wartofsky,et al.  Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[79]  Steven Henikoff,et al.  Spreading of silent chromatin: inaction at a distance , 2006, Nature Reviews Genetics.

[80]  E. Ballestar,et al.  The Epigenetic Face of Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.

[81]  P. Pozzilli,et al.  Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. , 2006, The Journal of clinical endocrinology and metabolism.

[82]  K. Osawa,et al.  Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. , 2006, Arthritis and rheumatism.

[83]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[84]  L. Hegedüs,et al.  High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. , 2005, The Journal of clinical endocrinology and metabolism.

[85]  P. De Meyts,et al.  Role of histone and transcription factor acetylation in diabetes pathogenesis , 2005, Diabetes/metabolism research and reviews.

[86]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Q. Lu,et al.  Demethylation of the Same Promoter Sequence Increases CD70 Expression in Lupus T Cells and T Cells Treated with Lupus-Inducing Drugs1 , 2005, The Journal of Immunology.

[88]  J. Bach,et al.  Infections and autoimmune diseases. , 2005, Journal of autoimmunity.

[89]  R. Leslie,et al.  Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. , 2004, Diabetes.

[90]  Antony V. Cox,et al.  DNA Methylation Profiling of the Human Major Histocompatibility Complex: A Pilot Study for the Human Epigenome Project , 2004, PLoS biology.

[91]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.

[92]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[93]  E. Li.  Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.

[94]  G. Wolff,et al.  Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. , 2002, The Journal of nutrition.

[95]  L. Poirier.  The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. , 2002, The Journal of nutrition.

[96]  D. Gutsch,et al.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[97]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[98]  A. Weetman.  Determinants of autoimmune thyroid disease , 2001, Nature Immunology.

[99]  W. Reik,et al.  Epigenetic Reprogramming in Mammalian Development , 2001, Science.

[100]  G. Kammer,et al.  Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-γ gene and protein expression in lupus T cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  J. Ilonen,et al.  Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. , 2000, Diabetes.

[102]  A. Bird,et al.  Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[103]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[104]  J. Ilonen,et al.  C o w ’ s Milk Consumption , HLA-DQB 1 Genotype , and Type 1 Diabetes A Nested Case-Control Study of Siblings of Children With Diabetes , 2000 .

[105]  J. Todd.  Genetics of type 1 diabetes. , 1997, Pathologie-biologie.

[106]  S Hanash,et al.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.